Add Formweb to your mobile device
Search results for:
melphalan flufenamide
melphalan flufenamide
Brand names: Pepaxto
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| POWDER FOR INJECTION, INTRAVENOUS | 20 mg | Non-formulary |
Last updated: May. 18, 2023
- Hazardous Drugs: View Hazardous Waste List
***A confirmatory phase 3 randomized trial in patients with relapsed or refractory multiple myeloma comparing melphalan flufenamide plus dexamethasone to pomalidomide plus dexamethasone demonstrated inferior overall survival outcomes in the melphalan flufenamide arm. Due to the trial results, the manufacturer is withdrawing melphalan flufenamide from the market.